 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | calcium lactate (OMT-111) / MetiMedi Pharma
New P2 trial: OMT-111 for Terminal Stage Solid Tumors (clinicaltrials.gov) - Aug 20, 2020
P2, N=78, Not yet recruiting, Sponsor: MetiMedi Pharmaceuticals